Immunotherapy: MAPK‐Targeted Drug Delivered by a pH‐Sensitive MSNP Nanocarrier Synergizes With PD‐1 Blockade in Melanoma Without T‐Cell Suppression (Adv. Funct. Mater. 12/2019)
Advanced Functional Materials - United Kingdom
doi 10.1002/adfm.201970079
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 1, 2019
Authors
Publisher
Wiley